Immunovant Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +4,652.4% | +23.4% | +7.5% | -82.6% | +63.2% | +8.5% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +86.2% | +43.1% | +48.4% | +57.4% | +32.9% | +69.5% | +26.5% | |
| – | – | – | +574.3% | +117.7% | +37.2% | -11.4% | +19.3% | +34.8% | -1.3% | |
| – | – | – | +13,257,011.1% | +81.2% | +44.3% | +33.5% | +29.7% | +62.2% | +21.6% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -100.0% | – | +1,805.6% | +299.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +410.5% | -469.1% | – | – | +6,200.0% | +57.1% | -75.9% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.